Stockscreener 앱 받기
38.65
2.05%
-0.81
전일 마감가:
$39.46
열려 있는:
$39.53
하루 거래량:
3.80M
Relative Volume:
0.93
시가총액:
$16.71B
수익:
$2.31B
순이익/손실:
$1.66B
주가수익비율:
16.83
EPS:
2.297
순현금흐름:
$827.02M
1주 성능:
-2.37%
1개월 성능:
+4.43%
6개월 성능:
+12.85%
1년 성능:
+48.60%
1일 변동 폭
$37.77
$39.69
1주일 범위
$37.77
$40.01
52주 변동 폭
$24.05
$41.24
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
38.65 | 16.86B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.76 | 61.08B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | Goldman | Buy |
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Why Royalty Pharma plc (RPD) stock could break out in 2025Quarterly Profit Summary & Risk Controlled Daily Plans - newser.com
What macro factors could drive Royalty Pharma plc (RPD) stock higher2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Will Royalty Pharma plc (RPD) stock maintain strong growthTrend Reversal & Precise Buy Zone Identification - newser.com
Royalty Pharma Insider Sold Shares Worth $2,735,329, According to a Recent SEC Filing - MarketScreener
Historical volatility pattern of Royalty Pharma plc visualizedTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsBond Market & Long-Term Growth Portfolio Plans - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcIndex Update & AI Driven Stock Reports - newser.com
Trading the Move, Not the Narrative: (RPRX) Edition - news.stocktradersdaily.com
Is Royalty Pharma plc (RPD) stock attractive post correctionWall Street Watch & Risk Managed Investment Signals - newser.com
How Royalty Pharma plc (RPD) stock compares with top peersWeekly Stock Analysis & Safe Capital Investment Plans - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessWeekly Market Report & High Accuracy Investment Signals - newser.com
Top chart patterns to watch in Royalty Pharma plcBull Run & Safe Capital Growth Plans - newser.com
Why analysts remain bullish on Royalty Pharma plc stockShare Buyback & Capital Efficient Trading Techniques - newser.com
Applying chart zones and confluence areas to Royalty Pharma plcQuarterly Risk Review & Daily Risk Controlled Trade Plans - newser.com
Royalty Pharma (RPRX): Is the Stock Undervalued After Higher 2025 Revenue Guidance and Major Buyback Completion? - Yahoo Finance
How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves - Yahoo Finance UK
Vise Technologies Inc. Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
Ontario Teachers Pension Plan Board Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat
Published on: 2025-11-18 06:12:54 - newser.com
Why retail investors pile into Royalty Pharma plc stockJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
Forsta AP Fonden Reduces Stake in Royalty Pharma PLC $RPRX - MarketBeat
Geode Capital Management LLC Has $299.49 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
What indicators show strength in Royalty Pharma plc2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
What analysts say about Royalty Pharma plc stockShort-Term Trading Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
What’s the recovery path for long term holders of Royalty Pharma plc - newser.com
What MACD signals say about Royalty Pharma plcTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
2.47%
자본화:
|
볼륨(24시간):